Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer.

Seydou SanogoPaolo SilimbaniRaffaella GaggeriRomina RossiLisa ElviriMarco MaltoniCarla Masini

Published in: European journal of hospital pharmacy : science and practice (2018)

This study confirms the analytical compatibility of MET and MID, when mixed in 0.9% sodium chloride at concentrations employed in our clinical practice.

Keyphrases

clinical practice
ms ms
simultaneous determination
high dose
mass spectrometry
tyrosine kinase
high performance liquid chromatography
low dose
solid phase extraction